(OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced the first patient enrolled in a Phase I dose ...

which is in a Phase III clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis; EP-104GI, which is in a Phase II clinical trial for the treatment of ...

vTv Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on the development of orally administered treatments for metabolic and inflammatory diseases. The company’s lead drug ...

Patients who completed Week 48 in BE HEARD I and BE HEARD II could enroll in the open-label extension study and received BIMZELX every two weeks (Q2W) or every four weeks (Q4W) based on ?90 percent ...

IPOPentixapharm Holding AG Sets Price Range for Planned IPO 23.09.2024 / 12:15 CET/CESTThe issuer is solely responsible for the content of this announcement.ADVERTISEMENTNOT FOR DISTRIBUTION OR ...

(Image Credits: Pixabay) Zydus on Tuesday announced the completion of its Phase II(a) clinical study of ... to conducting a larger Phase 2b clinical trial in consultation with the regulatory ...

This week on Pipeline Moves, the Clinical Trials Arena team investigates candidates in oncology, central nervous system and ...

Phase II trials are conducted to provide evidence of the effectiveness of a therapeutic intervention in patients and to determine the optimal treatment regimen (for example, dosing schedule ...